{"id":1600,"date":"2023-02-09T07:00:00","date_gmt":"2023-02-09T06:00:00","guid":{"rendered":"https:\/\/d3glparxwv1yl3.cloudfront.net\/annualreport\/press-releases\/ipsen-presente-de-solides-resultats-pour-lannee-2022-et-ses-objectifs-financiers-pour-2023\/"},"modified":"2023-05-23T14:11:17","modified_gmt":"2023-05-23T14:11:17","slug":"ipsen-presente-de-solides-resultats-pour-lannee-2022-et-ses-objectifs-financiers-pour-2023","status":"publish","type":"press_release","link":"https:\/\/www.ipsen.com\/annualreport\/fr\/press-releases\/ipsen-presente-de-solides-resultats-pour-lannee-2022-et-ses-objectifs-financiers-pour-2023\/","title":{"rendered":"Ipsen pr\u00e9sente de solides r\u00e9sultats pour l\u2019ann\u00e9e 2022 et ses objectifs financiers pour 2023"},"content":{"rendered":"
Paris (France), 9 f\u00e9vrier 2023<\/strong>
Ipsen (Euronext\u00a0: IPN\u00a0; ADR\u00a0: IPSEY), groupe biopharmaceutique mondial de sp\u00e9cialit\u00e9, pr\u00e9sente aujourd\u2019hui ses r\u00e9sultats financiers pour l\u2019exercice et le quatri\u00e8me trimestre\u00a02022.<\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"template":"","categories":[],"tags":[],"class_list":["post-1600","press_release","type-press_release","status-publish","hentry","entry"],"acf":[],"yoast_head":"\n